1[1]Fukuda M, Horibe K, Miyajima Y,et al. Chronic myelomonocytic leukemia developed 9 years after the diagnosis of idiopathic thrombocytopenic purpura in a child[J]. Rinsho Ketsueki, 1994, 35(6):609-615.
2[2]Sashida G, Takaku TI, Shoji N, et al. Clinico-hematologic features of myelodysplastic syndrome presenting as isolated thrombocytopenia: an entity with a relatively favorable prognosis[J]. Leuk Lymphoma, 2003, 44(4): 653-658.
3[3]Wang W, Matsuo T, Yoshida S,et al. Colony-forming unit-megakaryocyte (CFR-meg) numbers and serum thrombopoietin concentrations in thrombocytopenic disorders: an inverse correlation in myelodysplastic syndromes[J]. Leukemia, 2000, 14(10):1751-1756.
4Macchi L, Clofent-Sanchez G, Marit G, et al. PAICA : a method for characterizing platelet-associated antibodies-its application to the study of idiopathic thrombocytopenic purpura and to the detection of plateletbound c7 E3. Thromb Haemost, 1996,76 : 1020-1029.
5Richards EM, Baglin TP. Quantitation of reticulated platelets : methodology and clinical application. Br J haematol, 1995,91:445 -451.
6Deckmyn H, Reys SD. Functional effects of human antiplatelet antibodies. Semin Thromb Hemost,1995 ,21:46-59.
7Peterec SM, Brennan SA, Rinder HM, et al. Reticulated platelet values and thrombocytopenic neonates. J Pediatr, 1996,129:269-274.
